Saturday, 30 May 2026
  
Login

Australia's most trusted
source of pharma news

Saturday, 30 May 2026
News

Investor targets 'untapped market'

Posted 29 May 2026 AM

Partner at Factory Capital, Anna Samuelsson, is spearheading a push to build business around peri- and post-menopause interventions, with the Sydney-based private investment firm committing upwards of $25 million to target the “largely untapped market”.

Based on high unmet need for proper diagnoses and treatment, the estimated global market potential for interventions that address menopause symptoms ranges from US$120 billion to US$350 billion globally, according to a recent report produced by World Economic Forum in collaboration with the McKinsey Health Institute.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (18)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (3)

Other (8)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.